Cytokinetics Inc (NASDAQ:CYTK)

CAPS Rating: 3 out of 5

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer.

Results 1 - 19 of 19

Recs

0
Member Avatar ptanabe (83.36) Submitted: 9/9/2014 1:25:21 PM : Outperform Start Price: $3.67 CYTK Score: +29.81

ken

Recs

0
Member Avatar OKwarrior (43.59) Submitted: 6/6/2014 1:19:10 AM : Outperform Start Price: $4.88 CYTK Score: -5.91

It is down, but far from out. I am hoping for a rebound. They do have a cardiac drug remaining in the pipeline that has more than a frozen particulate sphere's chance in Hades

Recs

0
Member Avatar TerryFool (49.79) Submitted: 4/15/2014 11:55:35 AM : Outperform Start Price: $8.94 CYTK Score: -58.84

buy now target price 11

Recs

0
Member Avatar TerryHoodSr (61.58) Submitted: 4/15/2014 9:52:51 AM : Outperform Start Price: $8.94 CYTK Score: -58.13

trade buy@ 9 TP 11

Recs

0
Member Avatar s2dbaker (83.16) Submitted: 1/10/2014 2:14:10 PM : Outperform Start Price: $9.22 CYTK Score: -59.57

This stock is on the move (hopefully that move is up).

Recs

0
Member Avatar grahamfordummies (71.64) Submitted: 8/7/2013 7:49:09 PM : Outperform Start Price: $10.21 CYTK Score: -73.76

Low valuation ($299 million market cap) for two massive shots on goal. Omecamtiv in heart failure (with partner Amgen) and Tirasemtiv in ALS. 18 months of cash adequate to get through major milestones. Go big or go home.

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/6/2013 7:30:28 PM : Underperform Start Price: $10.55 CYTK Score: +75.87

Short. Biotech. Low revenues. Massive stock issuance.

Recs

0
Member Avatar kaletbaldrich27 (< 20) Submitted: 7/10/2013 12:23:01 PM : Outperform Start Price: $13.30 CYTK Score: -88.70

Wouldn't be surprised if this stock hit the high teens by the end of the year. Cramer doesn't know what he's talking about.

Recs

0
Member Avatar RBuskey106 (49.47) Submitted: 3/21/2012 8:23:55 PM : Outperform Start Price: $7.14 CYTK Score: -78.61

Bio play

Recs

0
Member Avatar Thleter (< 20) Submitted: 5/24/2011 1:07:51 PM : Outperform Start Price: $8.10 CYTK Score: -96.32

Following tenmiles, I like what I saw when doing my initial research. Will be checking up on it more to see if I'm ready to throw down some real coin on it.

Recs

0
Member Avatar cheaply (< 20) Submitted: 2/9/2011 4:08:24 PM : Outperform Start Price: $11.16 CYTK Score: -113.31

The bottom I hope.

Recs

0
Member Avatar riponfool (45.03) Submitted: 4/28/2010 12:25:32 PM : Outperform Start Price: $19.01 CYTK Score: -147.87

it will hit @ $ 10.15

Recs

0
Member Avatar Nmendez10 (< 20) Submitted: 5/30/2009 1:05:16 PM : Outperform Start Price: $17.94 CYTK Score: -195.80

Their drug developments and clinical trials are promising. I think they will do better in the future.

Recs

0
Member Avatar PennyStockFool (33.86) Submitted: 12/4/2008 2:57:44 PM : Underperform Start Price: $12.06 CYTK Score: +206.72

This one looks like it could be heaed to the scrap heep....

Recs

0
Member Avatar snaphooks (< 20) Submitted: 9/9/2008 11:18:52 PM : Underperform Start Price: $27.72 CYTK Score: +154.61

guru short

Recs

0
Member Avatar doneb1 (< 20) Submitted: 2/3/2008 4:59:56 PM : Outperform Start Price: $22.38 CYTK Score: -132.96

if even i of its drugs being tested prove successful, it will be a good thing for terminal patients and investors

Recs

0
Member Avatar tharlow (84.61) Submitted: 8/21/2007 3:00:29 AM : Outperform Start Price: $28.62 CYTK Score: -133.45

Bargain basement. Giving it away at these prices.

Recs

0
Member Avatar GravityProof (70.32) Submitted: 2/7/2007 11:52:24 PM : Outperform Start Price: $48.66 CYTK Score: -141.54

CYTK is undervalued by virtue of its pipeline, trials and tech. While many love other groups perceived to be similar such as EXEL, CYTK will excel (sorry) because of a relative lack of promiscuity between the drugs and their targets.

Recs

0
Member Avatar jeffbenes (< 20) Submitted: 9/23/2006 3:49:59 AM : Outperform Start Price: $37.20 CYTK Score: -153.46

Strong drug pipeline and strategic partnerships with major pharmaceutical companies.

Results 1 - 19 of 19

Featured Broker Partners


Advertisement